Junel 1/20 and Savaysa drug interactions - a phase IV clinical study of FDA data
Summary:
We study 1,058 people who take Junel 1/20 (ethinyl estradiol; norethindrone acetate) and Savaysa (edoxaban tosylate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Junel 1/20 and Savaysa. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Junel 1/20?
Junel 1/20 has active ingredients of ethinyl estradiol; norethindrone acetate. It is often used in birth control. eHealthMe is studying from 91 Junel 1/20 users. Check the latest studies of Junel 1/20.
What is Savaysa?
Savaysa has active ingredients of edoxaban tosylate. eHealthMe is studying from 967 Savaysa users. Check the latest studies of Savaysa.
No report is found.
Do you take Junel 1/20 and Savaysa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Junel 1/20 (91 reports)
- Savaysa (967 reports)
How the study uses the data?
The study uses data from the FDA. It is based on ethinyl estradiol; norethindrone acetate and edoxaban tosylate (the active ingredients of Junel 1/20 and Savaysa, respectively), and Junel 1/20 and Savaysa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tigan and Topamax - now
- Drug interactions of Klor-Con M10 and Zolpidem - 6 seconds ago
- Could Lipitor cause Pelvic Inflammatory Disease? - 9 seconds ago
- Drug interactions of Tricor and Krill - 12 seconds ago
- Could Namzaric cause Vomiting Aggravated? - 18 seconds ago
- Drug interactions of Celebrex and Fluorouracil - 20 seconds ago
- Could Lisinopril cause Intervertebral Disc Injury? - 23 seconds ago
- Drug interactions of Citalopram Hydrobromide and Ceftin - 26 seconds ago
- Hallucinations and drugs of ingredients of cannabidiol - 28 seconds ago
- Vitamin D and Melanocytic Naevus for Women aged 50-59 - 31 seconds ago